Elsevier

Neuroscience Letters

Volume 298, Issue 2, 2 February 2001, Pages 139-141
Neuroscience Letters

Erythropoietin exerts neuroprotection in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated C57/BL mice via increasing nitric oxide production

https://doi.org/10.1016/S0304-3940(00)01716-XGet rights and content

Abstract

Erythropoietin (EPO), produced by the kidney and fetal liver, is a cytokine-hormone that stimulates erythropoiesis under hypoxic conditions. It has been shown that EPO is produced in the central nervous system and its receptor is expressed on neurons. Since EPO has neuroprotective effects in vitro and in vivo against brain injury, we investigated the effect of EPO treatment on locomotor activities of animals, survival of nigral dopaminergic neurons and nitrate levels in substantia nigra and striatum in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced animal model of Parkinsonism in C57/BL mice. Our findings suggest that EPO has protective and treating effect in MPTP-induced neurotoxicity in this mouse model of Parkinson's Disease via increasing nitric oxide production.

Section snippets

Acknowledgements

The authors thank Dr Sezen Arat for obtaining C57BL mice. This study was supported by The Scientific and Technical Research Council of Turkey.

References (13)

There are more references available in the full text version of this article.

Cited by (0)

View full text